Phase 2, randomized trial (CONCERT-2) of panitumumab (PMAB) plus radiotherapy (PRT) compared with chemoradiotherapy (CRT) in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (LASCCHN)
J. Giralt
Phase 2, randomized trial (CONCERT-2) of panitumumab (PMAB) plus radiotherapy (PRT) compared with chemoradiotherapy (CRT) in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (LASCCHN)
J. Giralt